{
"info": {
"nct_id": "NCT02009631",
"official_title": "A Randomized, Placebo-Controlled Crossover Study to Evaluate the Effect of Veliparib (ABT-888) on Cardiac Repolarization in Subjects With Relapsed or Refractory Solid Tumors",
"inclusion_criteria": "* Confirmed solid malignancy that is metastatic or unresectable for which standard curative measures or other therapy that may provide clinical benefit do not exist or are no longer effective.\n* Subjects with brain metastases must have clinically controlled neurologic symptoms.\n* Subject is able to swallow and retain oral medications and does not have uncontrolled emesis.\n* Subject has adequate bone marrow, renal and hepatic function per local laboratory reference ranges.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
"exclusion_criteria": "* Uncorrected serum potassium, serum magnesium, serum calcium or free thyroxin (FT4) and thyroid stimulating hormone (TSH) outside of normal reference ranges, or grade 2 hyponatremia or hypernatremia.\n* Subject has severe ECG morphologic abnormalities that make QTc evaluation difficult.\n* Subject has a history of cardiac conduction abnormalities.\n* Subject has a significant history of cardiovascular disease.\n* Subject has received any anti-cancer therapies 21 days prior to the first dose of study drug, or has recovered to no better than a grade 2 or higher clinically significant adverse effect(s)/toxicity(s) of the previous therapy.\n* Use of drugs with a known risk for QT prolongation and Torsades de Pointes within 7 days prior to the first study dose.\n* Use of tobacco or nicotine-containing products within 12 hours prior to the first study dose.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Confirmed solid malignancy that is metastatic or unresectable for which standard curative measures or other therapy that may provide clinical benefit do not exist or are no longer effective.",
"criterions": [
{
"exact_snippets": "Confirmed solid malignancy",
"criterion": "solid malignancy",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "metastatic or unresectable",
"criterion": "malignancy status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"metastatic",
"unresectable"
]
}
},
{
"exact_snippets": "standard curative measures or other therapy that may provide clinical benefit do not exist or are no longer effective",
"criterion": "availability of effective therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Confirmed solid malignancy",
"criterion": "solid malignancy",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
},
{
"exact_snippets": "metastatic or unresectable",
"criterion": "malignancy status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"metastatic",
"unresectable"
]
}
},
{
"exact_snippets": "standard curative measures or other therapy that may provide clinical benefit do not exist or are no longer effective",
"criterion": "availability of effective therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Subjects with brain metastases must have clinically controlled neurologic symptoms.",
"criterions": [
{
"exact_snippets": "Subjects with brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "clinically controlled neurologic symptoms",
"criterion": "neurologic symptoms",
"requirement": {
"requirement_type": "control status",
"expected_value": "clinically controlled"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Subjects with brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "clinically controlled neurologic symptoms",
"criterion": "neurologic symptoms",
"requirement": {
"requirement_type": "control status",
"expected_value": "clinically controlled"
}
}
]
}
},
{
"identified_line": {
"line": "* Subject is able to swallow and retain oral medications and does not have uncontrolled emesis.",
"criterions": [
{
"exact_snippets": "Subject is able to swallow and retain oral medications",
"criterion": "ability to swallow and retain oral medications",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
},
{
"exact_snippets": "does not have uncontrolled emesis",
"criterion": "uncontrolled emesis",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Subject is able to swallow and retain oral medications",
"criterion": "ability to swallow and retain oral medications",
"requirement": {
"requirement_type": "ability",
"expected_value": true
}
},
{
"exact_snippets": "does not have uncontrolled emesis",
"criterion": "uncontrolled emesis",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Subject has adequate bone marrow, renal and hepatic function per local laboratory reference ranges.",
"criterions": [
{
"exact_snippets": "adequate bone marrow ... per local laboratory reference ranges",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
},
{
"exact_snippets": "adequate ... renal ... function per local laboratory reference ranges",
"criterion": "renal function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
},
{
"exact_snippets": "adequate ... hepatic function per local laboratory reference ranges",
"criterion": "hepatic function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate bone marrow ... per local laboratory reference ranges",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
},
{
"exact_snippets": "adequate ... renal ... function per local laboratory reference ranges",
"criterion": "renal function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
},
{
"exact_snippets": "adequate ... hepatic function per local laboratory reference ranges",
"criterion": "hepatic function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": "per local laboratory reference ranges"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 99 Years",
"criterions": [
{
"exact_snippets": "maximum age of 99 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 99,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 99 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 99,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Subject has severe ECG morphologic abnormalities that make QTc evaluation difficult.",
"criterions": [
{
"exact_snippets": "severe ECG morphologic abnormalities",
"criterion": "ECG morphologic abnormalities",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "make QTc evaluation difficult",
"criterion": "QTc evaluation",
"requirement": {
"requirement_type": "difficulty",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "severe ECG morphologic abnormalities",
"criterion": "ECG morphologic abnormalities",
"requirement": {
"requirement_type": "severity",
"expected_value": "severe"
}
},
{
"exact_snippets": "make QTc evaluation difficult",
"criterion": "QTc evaluation",
"requirement": {
"requirement_type": "difficulty",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Subject has a history of cardiac conduction abnormalities.",
"criterions": [
{
"exact_snippets": "history of cardiac conduction abnormalities",
"criterion": "cardiac conduction abnormalities",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "history of cardiac conduction abnormalities",
"criterion": "cardiac conduction abnormalities",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Subject has a significant history of cardiovascular disease.",
"criterions": [
{
"exact_snippets": "significant history of cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "history",
"expected_value": "significant"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "significant history of cardiovascular disease",
"criterion": "cardiovascular disease",
"requirement": {
"requirement_type": "history",
"expected_value": "significant"
}
}
}
},
{
"identified_line": {
"line": "* Subject has received any anti-cancer therapies 21 days prior to the first dose of study drug, or has recovered to no better than a grade 2 or higher clinically significant adverse effect(s)/toxicity(s) of the previous therapy.",
"criterions": [
{
"exact_snippets": "Subject has received any anti-cancer therapies 21 days prior to the first dose of study drug",
"criterion": "anti-cancer therapies",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 21,
"unit": "days"
}
}
},
{
"exact_snippets": "has recovered to no better than a grade 2 or higher clinically significant adverse effect(s)/toxicity(s) of the previous therapy",
"criterion": "adverse effect(s)/toxicity(s) of the previous therapy",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "grade"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Subject has received any anti-cancer therapies 21 days prior to the first dose of study drug",
"criterion": "anti-cancer therapies",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 21,
"unit": "days"
}
}
},
{
"exact_snippets": "has recovered to no better than a grade 2 or higher clinically significant adverse effect(s)/toxicity(s) of the previous therapy",
"criterion": "adverse effect(s)/toxicity(s) of the previous therapy",
"requirement": {
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "grade"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Use of drugs with a known risk for QT prolongation and Torsades de Pointes within 7 days prior to the first study dose.",
"criterions": [
{
"exact_snippets": "Use of drugs with a known risk for QT prolongation",
"criterion": "use of drugs with a known risk for QT prolongation",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 7 days prior to the first study dose"
}
},
{
"exact_snippets": "Use of drugs with a known risk for ... Torsades de Pointes",
"criterion": "use of drugs with a known risk for Torsades de Pointes",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 7 days prior to the first study dose"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Use of drugs with a known risk for QT prolongation",
"criterion": "use of drugs with a known risk for QT prolongation",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 7 days prior to the first study dose"
}
},
{
"exact_snippets": "Use of drugs with a known risk for ... Torsades de Pointes",
"criterion": "use of drugs with a known risk for Torsades de Pointes",
"requirement": {
"requirement_type": "timeframe",
"expected_value": "within 7 days prior to the first study dose"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Use of tobacco or nicotine-containing products within 12 hours prior to the first study dose.",
"criterions": [
{
"exact_snippets": "Use of tobacco or nicotine-containing products",
"criterion": "tobacco or nicotine use",
"requirement": {
"requirement_type": "time frame",
"expected_value": "within 12 hours prior to the first study dose"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Use of tobacco or nicotine-containing products",
"criterion": "tobacco or nicotine use",
"requirement": {
"requirement_type": "time frame",
"expected_value": "within 12 hours prior to the first study dose"
}
}
}
},
{
"identified_line": {
"line": "* Uncorrected serum potassium, serum magnesium, serum calcium or free thyroxin (FT4) and thyroid stimulating hormone (TSH) outside of normal reference ranges, or grade 2 hyponatremia or hypernatremia.",
"criterions": [
{
"exact_snippets": "Uncorrected serum potassium ... outside of normal reference ranges",
"criterion": "serum potassium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "Uncorrected serum magnesium ... outside of normal reference ranges",
"criterion": "serum magnesium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "Uncorrected serum calcium ... outside of normal reference ranges",
"criterion": "serum calcium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "Uncorrected ... free thyroxin (FT4) ... outside of normal reference ranges",
"criterion": "free thyroxin (FT4)",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "Uncorrected ... thyroid stimulating hormone (TSH) outside of normal reference ranges",
"criterion": "thyroid stimulating hormone (TSH)",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "grade 2 hyponatremia",
"criterion": "hyponatremia",
"requirement": {
"requirement_type": "severity",
"expected_value": "grade 2"
}
},
{
"exact_snippets": "grade 2 ... hypernatremia",
"criterion": "hypernatremia",
"requirement": {
"requirement_type": "severity",
"expected_value": "grade 2"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"or_criteria": [
{
"or_criteria": [
{
"or_criteria": [
{
"or_criteria": [
{
"or_criteria": [
{
"exact_snippets": "Uncorrected serum potassium ... outside of normal reference ranges",
"criterion": "serum potassium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
},
{
"exact_snippets": "Uncorrected serum magnesium ... outside of normal reference ranges",
"criterion": "serum magnesium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
}
]
},
{
"exact_snippets": "Uncorrected serum calcium ... outside of normal reference ranges",
"criterion": "serum calcium",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
}
]
},
{
"exact_snippets": "Uncorrected ... free thyroxin (FT4) ... outside of normal reference ranges",
"criterion": "free thyroxin (FT4)",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
}
]
},
{
"exact_snippets": "Uncorrected ... thyroid stimulating hormone (TSH) outside of normal reference ranges",
"criterion": "thyroid stimulating hormone (TSH)",
"requirement": {
"requirement_type": "range",
"expected_value": "outside of normal reference ranges"
}
}
]
},
{
"exact_snippets": "grade 2 hyponatremia",
"criterion": "hyponatremia",
"requirement": {
"requirement_type": "severity",
"expected_value": "grade 2"
}
}
]
},
{
"exact_snippets": "grade 2 ... hypernatremia",
"criterion": "hypernatremia",
"requirement": {
"requirement_type": "severity",
"expected_value": "grade 2"
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}